Clinical study offer

❤️ Paid Peripheral Artery Disease Clinical Trials

Browse recruiting peripheral artery disease clinical trials across the United States. Find eligibility information, locations and research opportunities near you.

Loading...
Active Studies
Peripheral Artery Disease
Condition

Active Clinical Trials for Peripheral Artery Disease

Showing live studies from ClinicalTrials.gov. Data refreshes daily.

Loading studies...

Disclaimer: This content is for educational purposes and is not medical advice. Always consult a qualified healthcare provider for medical guidance.

About Peripheral Artery Disease

Peripheral Artery Disease (PAD) is a circulatory condition where narrowed arteries reduce blood flow to the limbs, typically the legs. Clinical trials investigate new revascularization techniques, drug-coated balloons, and medical therapies to improve walking distance and prevent amputation.

Common Symptoms

Leg pain or cramping with walking (claudication), numbness or weakness in legs, cold feet, sores that do not heal, change in leg color, shiny leg skin, weak pulse in legs

Risk Factors

Smoking, diabetes, obesity, high blood pressure, high cholesterol, age (over 50), family history, kidney disease, metabolic syndrome

Treatment Overview

Treatment includes cilostazol, antiplatelet therapy, statins, supervised exercise therapy, and revascularization (angioplasty, stenting, bypass surgery). Clinical trials explore novel anti-restenosis therapies, gene therapy for angiogenesis, and drug-coated balloon technologies.

Why Participate?

Peripheral artery disease clinical trials advance treatment options that can improve mobility, reduce amputation risk, and address systemic cardiovascular risk.

Related Conditions

States with Peripheral Artery Disease Clinical Trials

Cities with Peripheral Artery Disease Clinical Trials

Frequently Asked Questions About Peripheral Artery Disease Clinical Trials

PAD clinical trials test new medications, stents, and balloon technologies to improve leg circulation and relieve walking pain. Studies explore both medical therapies and minimally invasive revascularization approaches.
Eligibility depends on PAD severity (ankle-brachial index), walking distance limitations, and prior revascularization history. Studies often include patients with claudication or critical limb ischemia.
Compensation varies. Participants may receive $75-$200 per visit with vascular imaging and study procedures provided at no cost.
Yes, participants receive regular vascular monitoring and cardiovascular assessments. All trials have independent safety oversight.